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Immune complexes  localized  in the kidneys of patients with systemic  lupus ery- 
thematosus (SLE) 1 appear to play a central role in the pathogenesis of glomerulone- 
phritis. Evidence supporting this hypothesis has been obtained from serial serologic 
studies (1-3), assay of specific antigen-antibody systems (4-7),  measurement of serum 
immune complex levels (8-11), and immunocytochemical  examination of tissues from 
patients with SLE (12-14). Following tissue deposition of  antigen-antibody complexes, 
the classical complement pathway may be activated in situ, generating complement 
fragments and effecting the release of cellular mediators (15). Chemotaxis, vasodila- 
tion, enhanced phagocytosis, initiation of coagulation, and local tissue damage may 
ensue  following complement  activation  (16). The  effector mechanisms  by  which 
complement-dependent immune complexes  induce injury to cells and membranes in 
vivo remain to be clarified. Proteolytic enzymes derived from neutrophils and serum, 
lymphokines, high molecular weight kininogen-kallikrein-Hageman factor coagula- 
tion  pathways,  and  the  terminal  complement complex  have  been  implicated  as 
mediators of cytotoxicity on the basis of in vitro studies (17). 
To  assess the  role  of the  terminal  complement  complex  in  the  inflammatory 
response, the tissue distribution of the membrane attack complex (MAC) comprised 
of C5b, C6, C7, C8, and C9, was investigated in kidneys manifesting SLE nephritis. 
In vitro studies have demonstrated that insertion of the MAC into the phospholipid 
bilayer of erythrocytes results  in disruption of the membrane and cell lysis (18). In 
addition, the  MAC  has  been  observed  on  the  surface  membranes of neutrophils 
obtained from patients with SLE (19), although the pathogenetic significance of this 
phenomenon has not been determined. In this study the MAC was demonstrated in 
both glomeruli and in the region of peritubular basement membranes of kidneys with 
morphologic evidence of SLE nephritis. These findings suggest that the MAC interacts 
with sites on renal basement membranes and functions in vivo as a direct mediator of 
nephrotoxicity. 
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and by the Pennsylvania State Department of Heahh. 
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Materials  and  Methods 
Tissues.  Renal tissue was obtained at autopsy (15 cases) and biopsy (7 cases) from patients 
with  clinical and  laboratory findings  that  fulfilled the  American  Rheumatism  Association 
criteria for SLE (20). SLE renal disease was classified as mesangial nephropathy (2 cases), focal 
proliferative glomerulonephritis (7 eases), diffuse proliferative glomerulonephritis (10  cases), 
and membranous nephropathy (3 cases). The categorization of renal disease (21-23) was based 
on microscopic review of hematoxylin-eosin- and periodic acid-Schiff (PAS)-stained sections of 
autopsy tissues and renal biopsies performed before reference to the immunofluorescence data. 
Clinical Data.  20 of 22 patients fulfilled previously described clinical criteria for active renal 
disease (24). One of two patients classified as mesangial nephropathy exhibited mild proteinuria 
(<1 g/24 h) and the second patient had no clinical evidence of renal dysfunction. One of the 
three patients with membranous nephropathy also had mild proteinuria and two patients had 
moderate to severe proteinuria (>3 g protein/24 h).  Two patients manifested signs of acute 
renal failure, but microscopic examination of the kidneys obtained at autopsy did not show 
evidence of acute tubular necrosis, and no differences were observed between these and other 
patients with SLE nephritis with respect to interstitial and peritubular mononuclear infiltration. 
Four  patients  with  diffuse  proliferative glomerulonephritis were  uremic  before  death  and 
manifested signs of advanced diffuse proliferative glomerulonephritis on microscopic exami- 
nation of their kidneys. 
Antisera.  Monospecific goat antisera to IgG, IgM, C3, and rabbit antisera to Clq (25) and 
C9  (26)  were prepared and  labeled with fluorescein (27).  Antiserum titers were determined 
before labeling and expressed as the dilution of serum that produced a reaction of equivalence 
with 0.2 mg/ml of purified antigen: anti-IgG-  1:5, anti-IgM-  1  : 1, anti-C3-1:  2, anti-C 1  q- 1  : 1, and 
anti-C9-1:1, using agar gel double diffusion. 
Antisera to C5b-9 neoantigen(s) were prepared in goats by injection of purified MAC (28) 
using a  modification of published methods  (29).  Antisera showing precipitin reactivity with 
whole serum determined by agar gel diffusion were absorbed with human plasma coupled to 
cyanogen-bromide-activated Sepharose 4B-CL. Antisera that reacted with purified MAC, but 
not with serum precursor proteins were considered specific for neoantigen(s) of the MAC. Both 
agar gel diffusion and bemagglutination of sheep erythrocytes bearing the C5b-9 complex were 
used for assay (29). Fluorescein/protein ratios of the antisera were as follows: anti-IgG-2.2, anti- 
IgM-l.9, anti-C3-2.5, anti-Clq-2.2, anti-C9-2.5, and anti-neoantigen(s)-2.4. Each fluorescein- 
ated antibody was  used at  a  maximum  dilution which  gave a  strong immunofluorescence 
reaction with positive control SLE kidney. 
Microscopy.  Renal tissue was quick-frozen in dry ice-isopentane at -90°C and sections were 
cut using a Harris cryostat (Harris Mfg. Co., Inc., N. Billeriea, Mass.). Cryostat sections were 
studied by the direct immunofluorescence method and examined by epi-illumination using a 
Leitz orthoplan  fluorescence  microscope  (E.  Leitz,  Inc.,  Rockleigh,  N. J.).  The  tissue was 
photographed with Ektaehrome 160 professional film (Eastman Kodak Co., Rochester, N. Y.). 
Specificity controls included the lack of reaction with three normal human  kidneys and the 
inhibition of positive staining by prior absorption with purified antigen. Sections from formalin- 
fixed, paraffin-embedded tissue were stained with hematoxylin-eosin and PAS before exami- 
nation by light microscopy. Electron microscopy was performed on sections of gluteraldehyde- 
fixed, plastic-embedded tissue from renal biopsies using a Zeiss EM9 electron microscope (Carl 
Zeiss, Inc., New York). 
A comparison of the stability of immunoglobulins, complement components, and MAC in 
tissues was studied in three kidneys (cases  107, 117, and  118) that  showed strongly positive 
immunofluorescence reactions for these proteins. Adherent cryostat sections were treated with 
1 M  NaCI, 0.2 M  glycine, pH 2.4, 0.1% sodium dodecyl sulfate, or digested with  1 mg/ml of 
fungat proteinase K  (Sigma Chemical Co., St. Louis, Mo.) for 3 h  at 37°C and washed with 
phosphate-buffered saline. The sections were evaluated before and after these treatments for 
the presence of IgG, C3, and MAC. 
Results 
I.  Immunopathology  of the Glomerular  Disease 
A.  MOaPHOLOGIC  HNDtNGS.  The  classification  of  SLE  nephritis  was  based  on G.  BIESECKER,  S.  KATZ,  AND  D.  KOFFLER  1781 
glomerular alterations as previously described  (21-23).  Electron microscopic exami- 
nation  of  glomeruli  from  five  renal  biopsies  was  consistent  with  the  glomerular 
pathology observed by light microscopy. 
B.  IMMUNOFLUOn~-SCENCE  Sa~DmS. Glomerular  localization  of  immunoglobulins, 
complement, and MAC is summarized in Table I. The intensity of immunofluores- 
cence was graded as strong, moderate, and weak or absent in order to compare the 
relative  amounts of detectable  IgG,  IgM,  Clq,  C3,  and  MAC,  within  each  of the 
three groups of renal disease. No significant differences were observed between biopsy 
and autopsy specimens except  for higher "background" staining for IgG and C3 in 
autopsy specimens. Sections from kidneys classified microscopically as focal prolifer- 
ative  glomerulonephritis  revealed  segmental  immunofluorescenee within  mesangial 
areas  and  capillary  walls  (Fig.  1 A).  The  deposits  were  comprised  of granular  or 
TABLE  I 
Glomerular Localization of lmmunoglobulins, Complement, and MAC 
Classification of 
glomerulonephritis 
Relative intensity of 
fluorescence 
Immunofluorescence 
demonstration of: 
IgG  IgM  Clq  C3  MAC 
Focal proliferative  (7)* 
Diffuse proliferative  (10) 
Membranous nephropathy  (3) 
Strong  74:  I  2  7  1 
Moderate  0  1  5  0  5 
Weak or absent  0  5  0  0  l 
Strong  9  0  6  8  8 
Moderate  1  5  4  2  2 
Weak or absent  0  5  0  0  0 
Strong  3  0  2  3  1 
Moderate  0  2  1  0  1 
Weak or absent  0  1  0  0  1 
* Number of cases studied showing positive reaction. 
:~ Number of cases showing reaction. 
Fro.  t.  Glomerular localization of IgG and MAC. Focal prolili~rative glomerulonephritis. (A) lgG. 
Extensive mesanglal deposits  (arrows) and segmental granular  aggregates  within capillary walls of 
glomerular tufts (×  400).  (B)  MAC. Similar distribution showing more discrete  deposits  with less 
intense fluorescence  staining (X 400). 1782  MEMBRANE  ATTACK  COMPLEX  IN  SYSTEMIC  LUPUS  ERYTHEMATOSUS 
FIG.  2.  Glomerular localization of C3 and MAC. Diffuse proliferative glomerulonephritis. (A) C3. 
Extensive granular and lumpy deposits similar to those found for IgG  (×  400).  (B)  MAC.  More 
extensive deposits than observed in Fig.  [ B, but less intense staining than evidenced in Fig. 2 A  (× 
400). 
FIG.  3.  Glomerular localization of IgG and MAC. Membranous nephr0pathy. Wire loop deposits 
along capillary walls of IgG (A), and MAC (B), showing similar distribution (× 400). 
TABLr  II 
Peritubular Inflammation 
Number of cases 
studied 
Tubules affected by infiltrate of 
mononuclear cells 
+*  ++  +++ 
Mesangial nephropathy 
Focal proliferative glomerulonephritis 
Diffuse proliferative glomerulonephritis 
Membranous nephropathy 
2  2  0  0 
7  4  2  1 
10  2  4  4 
3  1  I  1 
* +, <25%;  ++, 25-50'~ ; +++, >50'7,. G.  BIESECKER,  S.  KATZ,  AND  D.  KOFFLER  1783 
Fxc. 4.  (A) Diffuse infiltration of mononuclear cells surrounding proximal and distal convoluted 
tubules. Diffuse proliferative glomerulonephritis. PAS stain (× 150). (B) Mononuclear cell infiltrate 
contiguous to a proximal convoluted tubule. Focal proliferative glomerulonephritls. PAS stain (× 
400). (C) Thickened peritubular basement membrane with atrophy of  tubular epithelium, interstitial 
fibrosis and few inflammatory cells. Diffuse proliferative glomerulonephritis. PAS stain (× 250). (D) 
Higher power view of interstitial fibrosis and tubular atrophy. PAS stain (× 400). 
irregular  aggregates  containing  IgG,  C3,  and  Clq,  with  lesser  amounts  of IgM,  a 
pattern  characteristic  for immune  complex  localization.  Kidneys  with  moderate  to 
severe diffuse proliferative glomerulonephritis exhibited brighter immunofluorescence 
staining reactions, which were more diffuse and presented  as larger confluent aggre- 
gates with a  glomerular distribution  similar to that of focal glomerulonephritis  (Fig. 
2 A). Irnmunofluorescence demonstration of the MAC revealed more discrete deposits 
of lesser intensity for both types of glomerulonephritis  (Figs.  1 B and 2 B). 
Comparable  immunofluorescence reactions were observed  using either  anti-C9 or 
anti-neoantigen  sera for demonstration  of MAC. The MAC, IgG, C lq, and C3 were 
detectable  in a  similar distribution  indicating that immune complexes and the MAC 
were present  in close proximity. This phenomenon was most clearly demonstrated  in 
glomeruli from kidneys with membranous nephropathy. Diffuse subepithelial deposits 
with a  granular or wire loop appearance contained both immune complexes and the 
MAC  (Fig. 3).  Higher resolution than can be achieved by fluorescence microscopy is 1784  MEMBRANE  ATTACK COMPLEX  IN SYSTEMIC  LUPUS  ERYTHEMATOSUS 
Fro.  5.  Ultra.structure  of peritubular region. Membranous glomerulonephritis.  (A) Electron dense 
deposits  located  within and/or adjacent to tubular basement membrane. Appearance similar to 
subepithelial dense  deposits  found in glomeruli of the same biopsy (x  6,000). (B) The tubular 
basement membrane is thickened and frayed (arrow) (× 8,000). (Lead citrate,  uranyl acetate.) 
TABLE III 
Peritubular Localization of MAC 
Peritubular deposits of 
lgG and C3 
Number of kidneys with 
peritubular MAC  Classification of renal disease 
+*  ++  +++  Mes:~  FP  DP  Mem 
IgG, C3 absent  (7)§  3  3  1  2  2  2  I 
IgG absent, C3+  (8)  2  3  3  0  2  5  1 
IgG+, C3+  (5)  0  2  3  0  3  2  0 
IgG+,++ C3++  (2)  0  1  1  0  0  1  1 
* +, <25%; ++, 25-50%; +++, >50'7~. 
:~ Mes, tnesangial;  FP, focal proliferative:  DP, diffuse proliferative;  Mere, membranous nephropathy. 
§ Number of cases studied. 
required  for  determination  of the  precise  interrelationship  between  the  MAC  and 
antigen-antibody complexes. 
II.  Immunopathology  of Renal  Tubules 
A.  MORPHOLOGm  FINDINGS. Each  of  the  22  kidneys  manifesting  SLE  nephritis 
showed several or more foci of peritubular inflammation (Table II). Diffuse prolifer- 
ative glomerulonephritis was associated with the most severe inflammatory reactions. 
Focal and confluent areas of cellular infiltrate surrounded both  proximal and distal 
convoluted  tubules  (Fig.  4A).  In  contrast,  renal  tissues  showing  focal  proliferative 
glomerulonephritis or mesangial nephropathy contained discrete foci of inflammation 
predominantly  in the  region of proximal  tubules  (Fig. 4 B). The  infiltrates, whether G.  BIESECKER,  S.  KATZ,  AND  D.  KOFFLER  1785 
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Fro.  6.  Comparison of peritubular localization of IgG and cellular infiltrates for each case studied. 
Involved  tubules  graded  as  follows:  +,  <25%;  ++,  25-50%;  +++,  >50%  as  determined  by 
immunofluorescence or light microscopic examination. Autopsy (O). Biopsy (©). 
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Fro.  7.  Comparison of peritubular localization of C3 and cellular infiltration for each case studied. 
Involved  tubules  graded  as  follows:  +,  <25%;  ++,  25-50%;  +++,  >50%  as  determined  by 
immunofluorescence or light microscopic examination. 
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FIG.  8,  Comparison of peritubular  localization  of MAC  and  cellular  infiltration  for each  case 
studied. Involved tubules graded as follows: +, <25%; ++, 25-50%; +++, >50% as determined by 
immunofluorescence or light microscopic examination. 
focal or diffuse, were composed primarily of lymphocytes, plasma cells, and scattered 
neutrophils.  Both  proximal  and  distal  tubules  within  inflammatory  areas  showed 
degenerative  changes  marked  by  thickened  basement  membranes  evident  on  PAS 
stain, as well  as vacuolization and atrophy of the epithelium  (Fig.  4C).  Interstitial 
fibrosis (Fig. 4 D) with obliteration of tubules was found only in kidneys with moderate 1786  MEMBRANE  ATTACK  COMPLEX  IN  SYSTEMIC  LUPUS  ERYTHEMATOSUS 
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Flo.  9.  Comparison of glomerular and  peritubular  localization of MAC  for each case studied. 
Involved  tubules  graded  as  follows:  +,  <25%;  ++,  25-50%;  +++,  :>50%  as  determined  by 
immunofluorescence and  light  microscopic examination.  Peritubular  MAC scored as  in  Fig.  L 
Mesangial  nephropathy  ([S]); focal proliferative glomerulonephritis ((3);  diffuse proliferative glo- 
merulonephritis (0); membranous nephropathy (A). 
to severe proliferative glomerulonephritis. No microscopic evidence of acute pyelone- 
phritis was observed, although the presence of chronic pyelonephritis or a  primary 
interstitial  nephritis  could  not  be  excluded.  Tubules  in  five  renal  biopsies  were 
examined by electron microscopy. Immune complex-type dense deposits analogous to 
those  in  glomeruli  were  demonstrated  in  only  one  biopsy  (Fig.  5A),  a  case  of 
membranous nephropathy. These deposits were found mainly peripheral to tubular 
basement  membranes.  Microscopically, a  moderate  number  of inflammatory foci 
were present and IgG, Clq, C3, and the MAC were demonstrated in the peritubular 
region of this biopsy. Four biopsies manifested varying degrees of tubular basement 
membrane thickening with segmental fraying or splitting (Fig. 5 B). Marked irregular 
thickening of the tubular basement membrane was found by electron microscopic 
examination  in  one  patient  with  mild  proteinuria,  mesangial  nephropathy,  and 
isolated patches of the MAC without evidence of extra glomerular immunoglobulin 
or complement. Three other biopsies from patients with focal and diffuse proliferative 
glomerulonephritis and membranous nephropathy exhibited ultrastructural altera- 
tions  in  both  proximal  and  distal  tubular  basement  membranes  associated  with 
positive  immunofluorescence for  C3  and  MAC.  The  limited  number  of tubules 
available  for  study  in  these  biopsies  precluded  attempts  to  evaluate  correlations 
between ultrastructural and immunofluorescence findings. 
B.  IMMUNOFLUORESCENCE STUDIES. Peritubular  deposits  of IgG  and  foci  of Clq 
globulin were found in 7 of 22 cases (32%), whereas peritubular C3 and MAC were 
identified in higher incidence, 64% and 100%, respectively, in the 22 renal specimens 
studied (Table III). In contrast to IgG and C3, the MAC was closely correlated with 
loci of interstitial inflammation (Figs. 6-8). Control kidneys negative for peritubular 
MAC  included  three  kidneys without  renal  pathology, two  kidneys with  benign 
arteriolonephrosclerosis, and two renal biopsies with focal glomerulonephritis (non- 
SLE). A poor correlation was found between glomerular and tubular MAC localiza- 
tion for individual patients, except  for kidneys showing severe diffuse proliferative 
glomerulonephritis. These cases manifested extensive deposition of both peritubular 
and glomerular MAC (Fig. 9). A typical case of focal proliferative glomerulonephritis 
is  shown  in  Fig.  10:  absent  peritubular  IgG  (Fig.  10A),  small  clusters  of tubules G.  BIESECKER, S.  KATZ, AND  D.  KOFFLER  1787 
FIG. 10.  Peritubular localization of immune complex and MAC. Focal proliferative glomerulo- 
nephritis. Photomicrographs A, B, C, and D taken from cryostat sections of the same tissue block. 
(A) Localization of IgG in glomeruli. Note absence of staining in peritubular region (x  150). (B) 
Localization of C3  in glomeruli and surrounding small group of tubules (arrow) (x  150). (C) 
Localization of MAC in glomeruli (upper right) with prominent peritubular deposits (center) (X 
150). (D) Localization of peritubular MAC showing a discontinuous, thickened, linear pattern of 
deposits in the region of the tubular basement membrane (X 400). 
surrounded by C3 (Fig.  10 B), and MAC deposits in the peritubular region of a larger 
group of renal tubules (Fig.  10C).  MAC localization varied from an irregular linear 
pattern with segmental areas of thickening (Fig. 10 D) to irregular, granular aggregates 
shown in Fig.  11. 1788  MEMBRANE  ATTACK COMPLEX  IN  SYSTEMIC  LUPUS  ERYTHEMATOSUS 
Fl~.  11.  Tubular localization of lgG and MAC. Diffuse proliferative glomerulonephritis. (A) IgG 
staining  of intraluminal casts. Note absence of peritubular IgG (× 400). (B) Irregular granular 
aggregates of MAC surrounding tubules. Note the absence of staining of intraluminal casts (× 400). 
Fro. 12.  ~lization  of IgG and  MAC  in  the  wall of a  small  artery.  Diffuse proliferative 
glomerulonephritis.  (A) Segmental  deposition of IgG in an area of fibrinoid  necrosis, and (B) of 
MAC showing a more granular appearance in the same area (× 400). 
III.  lmmunopathology of Blood Vessels 
Vascular  deposits  of  immune  complexes  and  MAC  in  vessel  walls  were  most 
common in kidneys showing diffuse proliferative glomerulonephritis. Involvement of 
blood vessels ranged  from  small arterioles to  medium  sized arteries.  IgG, C3,  Clq, 
and  the  MAC  were  most  prominent  in  vessel walls showing fibrinoid necrosis  (Fig. 
12). No attempt was made to quantitate the incidence of vessel involvement because 
of the focal nature of the vasculitis. 
IV.  Elution of C~yostat Sections 
The  intensity  of  immunofluorescence  staining  for  IgG  and  C3  was  markedly 
reduced after incubation of sections from three kidneys with acid glycine or sodium 
dodecyl sulfate. The intensity of fluorescence for the MAC was only slightly decreased. 
Digestion with protease for  1 h  removed detectable IgG and C3, whereas the MAC G.  BIESECKER,  S.  KATZ,  AND  D.  KOFFLER  1789 
was not significantly affected. 
Discussion 
The MAC of complement was demonstrated by immunofluorescence at sites in 
renal glomeruli, blood vessels, and the periphery of proximal and distal convoluted 
tubules  in kidneys with microscopic  evidence of SLE nephritis. The renal  lesions 
encompassed the spectrum of SLE kidney disease ranging from mesangial nephrop- 
athy to focal and diffuse proliferative and membranous glomerulonephritis. Glomer- 
ular deposits of immune complexes  defined by the occurrence of IgG, Clq, and C3 
were uniformly accompanied by MAC. This complex exhibited weaker immunoflu- 
orescence staining and more discrete deposits in glomerular capillaries and mesangial 
areas.  Comparable amounts and a  similar distribution were observed  for immune 
complexes and MAC in the walls of blood vessels with fibrinoid necrosis. In contrast 
to the findings in glomeruli and blood vessels, a striking discordance was observed for 
the peritubular localization of MAC and immune complexes.  Tubular deposits  of 
MAC were present in kidneys of the 22 patients studied, whereas peritubular immune 
complexes  were absent from 65% of the renal specimens  examined. The MAC was 
observed in the tubular basement membrane region primarily in the form of  segmental 
and irregular thickened linear deposits. Fragmentation and thickening  of  the basement 
membrane with subepithelial dense deposits  were also observed by electron micro- 
scopic examination of renal biopsies in which the MAC deposits were demonstrated 
contiguous to tubules by immunofluorescence studies.  Inflammatory changes within 
the interstitium were frequently associated with tubular MAC deposits,  whereas a 
paucity of cellular infiltration was found in glomeruli even when heavy deposits  of 
MAC were demonstrable. 
The discordance noted for peritubular deposits  of MAC and immune complexes 
may be explained by one or more of the following hypotheses:  (a) Lesser amounts of 
peritubular  immunoglobulin  and  complement  are  more  amenable  to  metabolic 
degradation, whereas the MAC is intrinsically resistant to digestion by proteolytic 
enzymes (30). Insertion of MAC into the phospholipid membrane may also exert a 
protective effect (28). In vitro studies of cryostat sections incubated with acid and salt 
buffers, ionic detergents, or proteolytic enzymes indicated that MAC in tissue  is a 
relatively stable complex. (b) Binding sites required for the demonstration of immune 
complexes  may be masked or insufficient quantities of antigen-antibody complexes 
present for demonstration by immunofluorescence. (c) The alternative complement 
pathway may be more readily activated in tubulointerstitial regions by immunoglob- 
ulin-independent mechanisms, e.g., bacterial endotoxin (31), accounting for the failure 
to demonstrate peritubular IgG in most kidneys studied. 
The association of MAC with tissue  injury occurring in  glomeruli and tubules 
suggests that this terminal complement complex may cause damage without interven- 
tion of proteases derived either from neutrophils or serum. The MAC appears to cause 
physical disruption of the plasma membrane by creating membrane defects (18). In 
tissue  MAC  may damage plasma  membranes and  interfere with normal cellular 
function by disturbing osmotic balance without overt membrane lysis. The affinity  of 
MAC for phospholipid (32) may result in physical dissociation  of the plasma mem- 
brane and alteration of cellular architecture. These changes have been observed  at 
the muscle endplate in myasthenia gravis (33). In addition, the MAC binds to anionic 1790  MEMBRANE ATTACK COMPLEX IN SYSTEMIC LUPUS ERYTHEMATOSUS 
structures  and  may  interact  with  nonphospholipid  anionic  sites  located  between 
epithelium and basement membranes (34). 
Previous  investigations  have  demonstrated  that  experimental  immune  complex 
glomerulonephritis in rabbits may progress despite depletion of neutrophils (35). The 
failure to observe significant neutrophil infiltration in most forms of human glomer- 
ulonephritis also suggests that other pathways contribute to tissue injury. Deposition 
of MAC and interaction with basement and, perhaps, cellular membranes may be a 
common pathway for mediation of tissue injury involving both immune and nonim- 
mune initiated  inflammatory lesions.  Deposition of a  complement component, C3, 
but  not  of immunoglobulin  has  been  observed within  myocardial  infarction  (36). 
Although the presence of MAC in necrotic myocardial tissue has not been assessed, 
activation of the alternative complement pathway by tissue breakdown products may 
result in assembly of the MAC. 
The positive correlation between peritubular MAC and inflammation, independent 
of the presence of IgG and/or C3, suggests that this complex may be a more reliable 
marker for tissue injury. Tubulointerstitial nephritis studied by light, immunofluores- 
cence, and electron microscopy (37,  38) has been stressed as a potentially important 
factor contributing to the  destruction of renal  parenchyma and  the  progression of 
glomerulonephritis (37). The demonstration of the peritubular MAC, an agent with 
known potential for damaging membranes, lends further support to this thesis. In one 
patient with proteinuria,  immune complex deposits were limited to the glomerular 
mesangium, although peritubular MAC and ultrastructural thickening and fragmen- 
tation of tubular basement  membrane were demonstrated. These findings raise the 
possibility that  tubular dysfunction may have contributed to proteinuria. Tubular- 
associated immune complex deposits have been found in two patients with SLE and 
acute renal failure with histologically normal glomeruli. Heavy granular deposits of 
IgG, C lq, and C3 were observed surrounding damaged tubules, whereas glomerular 
deposits of IgG, Clq,  and  C3  were limited  to mesangial  areas  (39).  In  the present 
study,  the  kidneys  of two  patients  with  acute  renal  failure  showed  concomitant 
glomerular disease and, therefore, the tubular  contribution to  renal  failure was  dif- 
ficult  to evaluate.  The peritubular deposits  in  these patients showed no significant 
differences from those observed in patients without acute renal failure. Preliminary 
studies  of kidneys exhibiting morphologic evidence of pyelonephritis indicate  that 
MAC  is  predominantly interstitial  and  peritubular  (G.  Biesecker, S.  Katz, and  D. 
Koffler, unpublished observation), raising the possibility that tubular MAC in kidneys 
with SLE nephritis may reflect the occurrence of pyelonephritis as well as immune 
complex deposits. Although further studies are required to document the occurrence 
of subclinical interstitial pyelonephritis in patients with SLE, the consideration of this 
possibility has important therapeutic implications. 
The emphasis on tubulointerstitial disease in human glomerulonephritis during the 
past 5-10 yr may represent a more precise evaluation of renal pathology or, alterna- 
tively, may reflect a subtle change in the nature of renal pathology in SLE. Formation 
of immune complexes with an increased predilection for tubular localization and/or 
an  increased  prevalence of subclinical  pyelonephritis may  have  resulted  from  the 
utilization of more intensive immunosuppressive therapy. Experimental studies indi- 
cate that peritubular deposits are observed in most rabbits effected by chronic serum 
sickness disease induced by bovine serum albumin immunization (40)  and may also G. BIESECKER, S.  KATZ, AND D.  KOFFLER  1791 
be found in animals immunized with homologous kidney (41, 42), Therefore, immune 
complexes containing either exogenous or homologous antigens are capable of induc- 
ing extraglomerular lesions analogous to those found in the tubulointerstitial region 
of kidneys manifesting SLE nephritis.  However, the uniform presence of IgG in the 
experimental renal  lesions but  not  in  the  tubulointerstitial  lesions of SLE suggests 
that  several mechanisms  are operative in  the induction of tubular lesions found in 
SLE  patients.  Studies  are  currently  being  performed  in  an  attempt  to  identify 
alternative complement pathway components as well as bacterial antigens in the renal 
interstitium of kidneys with SLE nephritis. 
Parallel studies of the skin of patients with SLE indicate that the presence of MAC 
is associated with tissue injury. Clinically and microscopically uninvolved skin mani- 
fests  IgG  and  C3  containing  immune  complex  deposits  at  the  dermal-epidermal 
junction in >50% of patients with SLE particularly in association with renal disease 
(43, 44). A comparison of early acute inflammatory skin lesions with "normal" skin in 
patients with SLE indicates that MAC is present in the former and absent from the 
latter.  2 Therefore, the  terminal  complement complex is  present  at  sites containing 
antigen-antibody complexes only when  there  is  concomitant  inflammation.  These 
preliminary data provide additional support for the thesis that MAC is both a marker 
for demonstration of tissue injury and  a  mediator of the inflammatory response in 
SLE nephritis. 
Summary 
The membrane attack complex (MAC) of the complement system was localized in 
both  glomeruli  and  peritubular  regions  of 22  kidneys  manifesting  systemic  lupus 
erythematosus  (SLE)  nephritis.  A  similar  distribution  was  observed  for  immune 
complex markers (IgG, Clq, and C3) and MAC in glomeruli, although the deposits 
of MAC were more discrete and showed lesser immunofluorescence staining intensity 
compared with immunoglobulins and complement components. In contrast, peritu- 
bular immune complexes were present in only 7 out of 22 kidneys, involved compar- 
atively small clusters of tubules, exhibited weaker immunofluorescence staining than 
MAC,  and  failed  to  correlate with  interstitial  foci  of inflammation.  Granular  or 
irregular  linear  aggregates  of the  MAC  were  observed  at  the  periphery of larger 
groups  of  tubules  contiguous  to  areas  of interstitial  inflammation.  Comparable 
amounts of IgG, Clq, C3, and  MAC were present  in blood vessel walls in areas of 
fibrinoid necrosis. These data suggest  that  the MAC  is a  direct mediator of tissue 
injury  occurring  in  renal  glomeruli,  tubules,  and  blood  vessels.  The  discordance 
between immune complexes and MAC localized in the peritubular region, but not in 
glomeruli or blood vessels,  raises the  possibility that  both  immune complexes and 
nonimmune agents, such as bacterial antigens, may activate the classical or alternative 
complement pathways and thereby play a role in the pathogenesis of tubulointerstitial 
lesions of SLE nephritis. 
The authors are indebted to Chui-Mei  Sung  for excellent  technical assistance  and  to the 
clinicians  and pathologists  who allowed  the investigators  to study specimens obtained from 
patients with SLE at their institutions. 
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